- Current report filing (8-K)
June 01 2011 - 8:31AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): June 1, 2011
MEDCO HEALTH SOLUTIONS,
INC.
(Exact name of registrant as
specified in its charter)
|
|
|
|
|
Delaware
|
|
1-31312
|
|
22-3461740
|
(State or other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
|
|
100 Parsons Pond Drive,
Franklin Lakes, NJ
|
|
07417
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant’s telephone number,
including area code:
201-269-3400
|
|
(Former name or former address if changed since last report.)
|
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item 7.01 Regulation FD
Disclosure.
Senior members of
Medco Health Solutions, Inc.’s (the “Company”) management
team will be making a presentation at the Sanford C. Bernstein 27
th
Annual Strategic
Decisions Conference on Wednesday, June 1, 2011 at 10:00 a.m. Eastern
Time at the Waldorf Astoria Hotel in New York City. A live audio webcast of the
Company’s presentation at the conference will be available on the
Company’s Investor Relations website at
www.medcohealth.com/investor
. A replay of the Company’s
presentation will also be available on the Company’s website for one
month following the presentation. The slides accompanying the presentation are
attached to this Current Report on Form 8-K (“Current Report”) as
Exhibit 99.1 and are incorporated herein solely for purposes of this
Item 7.01 disclosure. These materials will also be available on the
Company’s Investor Relations website at
www.medcohealth.com/investor
.
The information in
Item 7.01 of this Current Report, including Exhibit 99.1 attached
hereto, is being furnished and shall not be deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended,
or otherwise subject to the liabilities of such section. The information in
Item 7.01 of this Current Report, including Exhibit 99.1 attached
hereto, shall not be incorporated by reference into any registration statement
or other document pursuant to the Securities Act of 1933, as amended.
Item
9.01 Financial
Statements and Exhibits.
|
Exhibit No.
|
|
Description
|
|
99.1
|
|
Slide Presentation for the Sanford C. Bernstein 27
th
Annual Strategic
Decisions Conference on Wednesday, June 1, 2011
|
2
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
MEDCO HEALTH
SOLUTIONS, INC.
Date: June 1, 2011
By:
/
s/ Thomas M.
Moriarty
Thomas M. Moriarty
General Counsel, Secretary and
President, Global
Pharmaceutical
Strategies
3
EXHIBIT INDEX
|
Exhibit No.
|
|
Description
|
|
99.1
|
|
Slide Presentation for the Sanford C. Bernstein 27
th
Annual Strategic
Decisions Conference on Wednesday, June 1, 2011
|
4
Medco (NYSE:MHS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medco (NYSE:MHS)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Medcohealth Solutions Common Stock (New York Stock Exchange): 0 recent articles
More News Articles